Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma

NCT02200042 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT02200042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02200042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Terminated
Start date
September 29, 2014
Completion date
July 2, 2018
Enrollment
1 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii intrahepatic cholangiocarcinoma, stage iva intrahepatic cholangiocarcinoma